; (C) develop expedited safe and effective prophylactics and therapeutics that are accessible and affordable; (D) coordinate the communication of timely and accurate information to WHO member states during global pandemics; and (E) ensure effectiveness, coordination, transparency, and accountability of international global health organizations. (b) Panel of experts on global pandemics (1) In general The Secretary of State, in consultation with the Secretary of Health and Human Services and the Administrator of the United States Agency for International Development, shall establish a panel of experts on global pandemics (in this Act referred to as the panel of experts ) to assist in carrying out the review and assessment required by subsection (a) and to develop the recommendations required by paragraph (3). (2) Membership The membership of the panel of experts shall consist of the following: (A) At least 2 representatives of nongovernmental organizations with expertise in, and dedication to providing, international medical care, to be appointed by the Secretary of State. (B) At least 2 representatives from academia or civil society with expertise in United Nations reform, to be appointed by the Secretary of State. (C) The Director of the Centers for Disease Control and Prevention. (D) The Director of the National Institutes of Health. (E) The Assistant Secretary of State for International Organization Affairs. (F) The U.S. Special Representative for Global Health Diplomacy. (G) The Assistant Administrator for the United States Agency for International Development’s Bureau for Global Health. (H) Four individuals with expertise in infectious disease pandemics, the WHO, and the WHO’s International Health Regulations, of which— (i) one individual shall be appointed by the Speaker of the House of Representatives; (ii) one individual shall be appointed by the majority leader of the Senate; (iii) one individual shall be appointed by the minority leader of the House of Representatives